Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | PREP | P48147 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9506098 | 0.95 | L3MBTL1 (0.53) | CASP1ALDH1A1L3MBTL1TSHRPREP | |
| SCHEMBL28516086 | 0.93 | L3MBTL1 (0.55) | CASP1ALDH1A1L3MBTL1PREP | |
| Trifluoroacetic Acid SCHEMBL6601200 | 0.90 | CASP1 (0.57) | CASP1ALDH1A1L3MBTL1PREP | |
| SCHEMBL1934716 | 0.89 | ALDH1A1 (0.50) | CASP1ALDH1A1L3MBTL1TSHR | |
| SCHEMBL6628631 | 0.83 | CASP1 (0.41) | CASP1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL6602304 | 0.81 | CASP1 (0.39) | CASP1ALDH1A1 | |
| SCHEMBL13386604 | 0.80 | ALDH1A1 (0.55) | ALDH1A1TSHR | |
| SCHEMBL15592597 | 0.79 | ALDH1A1 (0.40) | ALDH1A1TSHR | |
| SCHEMBL5871698 | 0.79 | ALDH1A1 (0.41) | CASP1ALDH1A1 | |
| SCHEMBL21281736 | 0.79 | CASP1 (0.53) | CASP1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865867-A | Synthesis method of 3-methyl-3-carbamic acid tert-butyl ester pyrrolidine-5-ketone | 南通敏言生物医药科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117865867-A | Synthesis method of 3-methyl-3-carbamic acid tert-butyl ester pyrrolidine-5-ketone | 南通敏言生物医药科技有限公司 | 2024-04-12 | — | — | CN | disclosed |
| WO-2003105827-A1 | NEUROPROTECTION AND CARDIOPROTECTION AFFORDED BY CHELATORS WITH HIGH AFFINITY AND SPECIFICITY FOR CATIONS OF FIRST TRANSITION SERIES ELEMENTS | CONCAT, LTD. (US) | 2003-12-24 | — | — | WO | disclosed |
| EP-0944587-B1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 2002-03-20 | — | — | EP | disclosed |
| EP-0944587-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1999-09-29 | — | — | EP | disclosed |
| US-5840974-A | Metalloproteinase inhibitors | BRITISCH BIOTECH PHARMACEUTICALS, LTD. (GB) | 1998-11-24 | — | — | US | disclosed |
| WO-1998024759-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1998-06-11 | — | — | WO | disclosed |